Hylan g-f 20 Pregnancy and Breastfeeding Warnings
Brand names: Synvisc, Synvisc-One
Medically reviewed by Drugs.com. Last updated on Aug 21, 2023.
Hylan g-f 20 Pregnancy Warnings
Animal studies have not been conducted with this drug. There are no controlled data in human pregnancy. It is not known whether this drug can cause fetal harm or adversely affect reproductive capacity in humans.
US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D and X are being phased out.
Safety has not been established during pregnancy.
US FDA pregnancy category: Not assigned.
Risk Summary: Animal and human studies have not been reported.
Hylan g-f 20 Breastfeeding Warnings
Safety has not been established.
Excreted into human milk: Unknown
Excreted into animal milk: Data not available
Comments:
-The effects in the nursing infant are unknown.
See also
References for pregnancy information
- Product Information. Synvisc (hylan G-F 20). Wyeth-Ayerst Laboratories. PROD.
References for breastfeeding information
- Product Information. Synvisc (hylan G-F 20). Wyeth-Ayerst Laboratories. PROD.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
